Biotechnology News

September 29, 2014

LOS ANGELES--(BUSINESS WIRE)--PBYI announced positive initial data from the ongoing, open label Phase II clinical trial of its investigational drug PB272 (neratinib) for the treatment of patients with NSCLC with HER2 mutations.

September 29, 2014

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Biopharmaceuticals Data Presented at ESMO 2014 Congress Show Ablative, Bystander Effects of PV-10

September 29, 2014

GÖTEBORG, Sweden & RADNOR, Pa.--(BUSINESS WIRE)--Cortendo AB (OAX:CORT) Cortendo AB [ticker: CORT on NOTC-A], a biopharmaceutical company developing and commercializing products at the intersection of orphan diseases and endocrinology...

September 29, 2014

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck Announces First Presentation of Early Data on the Investigational Use of KEYTRUDA® (pembrolizumab) in Patients with Advanced Bladder Cancer at ESMO 2014

September 29, 2014

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--MSD Announces First Presentation of Early Data on the Investigational Use of Pembrolizumab in Patients with Advanced Bladder Cancer at ESMO 2014

September 29, 2014

DARMSTADT, Germany--(BUSINESS WIRE)--Product innovations and geographical expansion drive sustained Merck Consumer Health business growth

September 29, 2014

HARROGATE, England--(BUSINESS WIRE)--Mayor and Mayoress Open Smithers Viscient EU Research Laboratory in Harrogate

September 29, 2014

PRINCETON, N.J.--(BUSINESS WIRE)--Positive Phase 3 Data for Opdivo (nivolumab) in Advanced Melanoma Patients Previously Treated with Yervoy (ipilimumab) Presented at the ESMO 2014 Congress; First Presentation of Phase 3 Results.

September 29, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced positive data from the coBRIM Phase III study. The results showed that people with previously untreated BRAF V600...

September 29, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis Inc. (NASDAQ:EXEL) today announced the positive results from coBRIM, the phase 3 pivotal trial conducted by Exelixis’ collaborator Genentech, a member of the Roche Group, evaluating...

September 29, 2014

GÖTEBORG, Sweden and RADNOR, Pa.--(BUSINESS WIRE)--Regulatory News: Cortendo AB(OSE:CORT): Cortendo AB [ticker: CORT on NOTC-A], a biopharmaceutical company developing and commercializing products at the intersection of orphan diseases and...

September 29, 2014

BURTON-ON-TRENT, England--(BUSINESS WIRE)--Clinigen Group plc Receives FDA’s First Ever Drug Shortage Assistance Award

September 29, 2014

STRASBOURG, France--(BUSINESS WIRE)--Regulatory News: Transgene SA (NYSE-Euronext: TNG)(Paris:TNG) today announced the presentation1 of more mature data from the Phase 2b part of the TIME trial with TG4010 MUC1 targeted immunotherapy at the...

September 28, 2014

SAN DIEGO--(BUSINESS WIRE)--Ignyta, Inc. (Nasdaq: RXDX), an oncology precision medicine biotechnology company, announced today that interim results from the first-in-human ALKA-372-001 Phase I clinical trial of RXDX-101, the company’s proprietary...

September 28, 2014

LONDON--(BUSINESS WIRE)--Updated data from the ongoing AURA study of AZD9291 shows encouraging, although still immature, median progression free survival of 9.6 months (95% CI 8.3 to NC) in patients with epidermal growth factor receptor mutation...

September 28, 2014

EAGAN, Minn.--(BUSINESS WIRE)--Biothera will present today results on its investigational immunotherapy Imprime PGG® in combination with standard of care frontline chemotherapy and bevacizumab in patients with stage IV nonsquamous non-small cell...

September 28, 2014

BEERSE, Belgium--(BUSINESS WIRE)--ZYTIGA® Plus Prednisone Demonstrates Statistically Significant Overall Survival After 49-Month Follow-Up Analysis in Chemotherapy-Naïve Men with Metastatic Castration-Resistant Prostate Cancer

September 28, 2014

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--MSD Announces First Presentation of Data on the Investigational Use of Pembrolizumab in Patients with Advanced Gastric Cancer at ESMO 2014

September 28, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced final survival results from the Phase III CLEOPATRA study, which showed that adding Perjeta® (pertuzumab) to...

September 28, 2014

BOULDER, Colo.--(BUSINESS WIRE)--Clovis reports updated data from Phase 2 studies of rucaparib at ESMO 2014

September 27, 2014

INGELHEIM, Germany--(BUSINESS WIRE)--For Ex-US and Ex-UK Media Only Phase III data from Boehringer Ingelheim’s LUX-Lung 8 trial, the first study to directly compare the efficacy of two different targeted agents in patients with advanced squamous...

September 27, 2014

PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced the presentation at the ESMO 2014 Congress (26-30 September in Madrid) of the preliminary results of the phase II proof-of-concept clinical trial with...

September 26, 2014

DALLAS--(BUSINESS WIRE)--Vivione Biosciences Inc. today announced the termination of Ted Moskal as President of Vivione and its operating subsidiary, Vivione Biosciences, LLC.

September 26, 2014

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN) today announced that its management will host a conference call and webcast on Monday, September 29, 2014, at 5:30 a.m. Pacific Time (PT) / 8:30 a.m. Eastern Time (ET)...

September 26, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida Reports FDA approval of ILUVIEN for Diabetic Macular Edema - pSivida earns $25 million milestone payment

September 26, 2014

TALLAHASSEE, Fla.--(BUSINESS WIRE)--Global Green responds to SEC action and is immediately appealing trading halt decision.

September 26, 2014

MADISON, Wis.--(BUSINESS WIRE)--Five Wisconsin bioscience companies have been selected as the winners of BIOforward’s 2014 Emerging Company Showcase, sponsored by The Center for Technology Commercialization, Madison Gas and Electric (MGE), and...

September 26, 2014

--(BUSINESS WIRE)--Quintiles, a Fortune 500 company, is the world’s largest provider of biopharmaceutical development and commercial outsourcing services. With a network of more than 30,000 employees conducting business in approximately 100...

September 26, 2014

--(BUSINESS WIRE)--Since 1963 Cook Medical has worked closely with physicians to develop technologies that eliminate the need for open surgery. Today we are combining medical devices, biologic materials and cellular therapies to help the world's...

September 26, 2014

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces that Merck, known as MSD outside the United States and Canada, has received approval for NOXAFIL® (posaconazole) 300 mg Concentrate for Solution for Infusion...

September 26, 2014

NEW YORK--(BUSINESS WIRE)--Recap of stories on Business Wire related to Breast Cancer Awareness Month 2014

September 26, 2014

INGELHEIM, Germany--(BUSINESS WIRE)--For media outside UK and US only Boehringer Ingelheim today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for the...

September 26, 2014

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea announces the CHMP has adopted a positive opinion recommending the granting of marketing authorization for Lymphoseek in Europe for use in breast cancer, melanoma and head and neck cancers.

September 26, 2014

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency, has adopted a positive opinion...

September 26, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Oncology (NASDAQ:AVEO) today announced that, as part of its plan to decrease operational expenses, the Company has entered into a termination of its lease agreement pertaining to the Company’s headquarters...

September 26, 2014

DUESSELDORF, Germany--(BUSINESS WIRE)--miacom diagnostics GmbH announces Health Canada Approval for hemoFISH assays, a platform technology to analyze positive blood cultures in 30 minutes

September 26, 2014

TAIPEI, Taiwan--(BUSINESS WIRE)--PharmaEngine, Inc. (TWO: 4162), announced today that the company has signed an Amendment to its License Agreement of MM-398 (aka PEP02, nanoliposomal irinotecan injection, nal-IRI) with Merrimack Pharmaceuticals,...

September 25, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec to Report Third Quarter 2014 Financial Results on October 22, 2014.

September 25, 2014

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) will host a quarterly conference call to discuss its third quarter 2014 financial results on Thursday, October 16, 2014, at 7:30 a.m. Central Time. To access the call, please...

September 25, 2014

SAN DIEGO--(BUSINESS WIRE)--Ignyta, Inc. (Nasdaq: RXDX), an oncology precision medicine biotechnology company, announced today that Jacob Chacko, M.D., Chief Financial Officer, will make a presentation at the Livingston Securities Life Science...

September 25, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Researchers at Stanford University have demonstrated the ability to predict the recovery time of patients who underwent surgical trauma. Researchers used Fluidigm’s CyTOF® Mass Cytometry Instrument....

September 25, 2014

SEATTLE--(BUSINESS WIRE)--Chris Rivera (WBBA) announced today that Steven Gillis, PhD (ARCH Venture Partners), has been confirmed as keynote speaker for the Governor’s Life Sciences Summit and Annual Meeting Friday, Oct. 24.

September 25, 2014

POMONA, Calif.--(BUSINESS WIRE)--PSC Software announces the release of a highly-configurable, modular Enterprise Quality Management System, Adaptive Compliance Engine, ACE!

September 25, 2014

WASHINGTON--(BUSINESS WIRE)--Marker Test Diagnostics, an international supplier to the drug testing industry, announced today that UR Code™, its revolutionary drug testing marker is now available in the United States. Once only available in...

September 25, 2014

LONDON & BOSTON & TOKYO--(BUSINESS WIRE)--The median price of the Top 100 drugs has skyrocketed from $1,260 in 2010 to $9,400 in 2014, representing a seven-fold increase, according to Evaluate’s new USA Sales, Volume and Pricing Analysis...

September 25, 2014

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”; OTCBB:ACTCD), a leader in the field of regenerative ophthalmology, announced today that it has completed treatment of the final patient in its U.K. based Phase 1 clinical...

September 25, 2014

EXTON, Pa.--(BUSINESS WIRE)--Fibrocell Science, Inc., (NASDAQ:FCSC), an autologous cell therapy company focused on developing first-in-class treatments for rare and serious skin and connective tissue diseases with high unmet medical needs, today...